The aim of our study was to examine cognitive performance
in relation to pharmacological daily doses of antipsychotic
and anticholinergic medications and their combination
within specific cognitive domains, namely, declarative memory,
information processing, executive function, and attention.
As expected for patients suffering from schizophrenia
the baseline cognitiveperformance for all variableswas below
the one expected for a control population. At a descriptive
level patients without medication tended to perform better
than those with medication, although still impaired in many
different tasks.